Education
About Us
Working with TipRanks
Follow Us
Intuitive Surgical (ISRG)
NASDAQ:ISRG
ISRG Stock Chart & Stats
$546.76
$11.55(2.17%)
At close: 4:00 PM EST
$546.76
$11.55(2.17%)
Day’s Range― - ―
52-Week Range$425.00 - $616.00
Previous CloseN/A
Volume485.62K
Average Volume (3M)1.44M
Market Cap
$193.82B
Enterprise Value$157.01B
Total Cash (Recent Filing)$4.91B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)72.4
Beta1.18
Next Earnings
Jan 22, 2026EPS Estimate
2.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.40
Shares Outstanding354,496,060
10 Day Avg. Volume1,371,199
30 Day Avg. Volume1,435,493
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)11.28
Price to Sales (P/S)22.20
P/FCF Ratio142.20
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue16.33
Enterprise Value/Gross Profit24.60
Enterprise Value/Ebitda43.84
Forecast
1Y Price Target
$637.32Price Target Upside16.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
EPS Forecast (FY)9.7
Revenue Forecast (FY)$11.39B
Bulls Say, Bears Say
Bulls Say
Dv5 Adoption And Upgrade CycleStrong Dv5 adoption is driving system placements and supports an upgrade cycle that boosts instruments and accessories revenue due to the new model's price premium.
Placements, Utilization And Geographic ExpansionHigher system placements combined with rising utilization and expansion into international markets and ambulatory surgical centers supports ongoing procedure growth and recurring revenue upside.
Product Pipeline And Imaging InnovationAdvanced initiatives like JURA, Trident, SSOP imaging, and AI-enabled guidance expand clinical capabilities and open opportunities to grow the addressable market by enabling new procedure types and better outcomes.
Bears Say
Macro And Competitive HeadwindsTariffs, a constrained capital spending environment, and intensifying competition could dampen hospital capital purchases, reduce system placements, and pressure earnings per share.
Procedure Guidance RiskProcedure growth guidance that falls short of prior expectations can disappoint investors and limit instruments and consumables revenue if volumes do not accelerate.
Valuation PressureA premium valuation versus large medtech peers raises the bar for future updates and makes the stock vulnerable to any operational or guidance miss.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was $425.00 and its highest was $616.00 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $193.82B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Jan 22, 2026 which is in 6 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Oct 21, 2025. The company reported $2.4 earnings per share for the quarter, beating the consensus estimate of $1.995 by $0.405.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 2.25.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 354,496,060 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $2.4 in its last earnings report, beating expectations of $1.995. Following the earnings report the stock price went up 13.893%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in ISRG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$637.32 (16.56% Upside)
$637.32 (16.56% Upside)
Blogger Sentiment
Bullish
ISRG Sentiment 82%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 517.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 8.5%
Last 30 Days ▲ 8.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.46%
12-Months-Change
Fundamentals
Return on Equity
16.90%
Trailing 12-Months
Asset Growth
9.06%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
ISRG Company Deck
ISRG Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong growth in revenue, procedures, and technological advancements with successful international expansion and positive clinical outcomes. However, challenges persist in the Chinese market and domestic bariatric procedures decline, with some concerns over net placements.View all ISRG earnings summariesISRG Revenue Breakdown
66.92% U.S.
33.08% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
$637.32
▲(16.56% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Hologic
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
0.45% Insiders
22.59% Mutual Funds
0.87% Other Institutional Investors
50.76% Public Companies and Individual Investors